Alkermes (ALKS) Capital Expenditures (2010 - 2026)

Alkermes (ALKS) has 17 years of Capital Expenditures data on file, last reported at $4.1 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $4.1 million, down 59.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.4 million (down 2.42% YoY), and the FY2025 annual result was $40.4 million, up 20.71% from the prior year.
• Capital Expenditures grew to $4.1 million in Q1 2026 per ALKS's latest filing, from -$20000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $17.3 million in Q3 2025 and troughed at -$20000.0 in Q4 2025.
• A 5-year average of $9.7 million and a median of $9.8 million in 2024 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 117.62% in 2022, then tumbled 100.2% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $10.0 million in 2022, then jumped by 69.82% to $17.0 million in 2023, then slumped by 42.61% to $9.8 million in 2024, then tumbled by 100.2% to -$20000.0 in 2025, then soared by 20550.0% to $4.1 million in 2026.
• Business Quant data shows ALKS's Capital Expenditures at $4.1 million in Q1 2026, -$20000.0 in Q4 2025, and $17.3 million in Q3 2025.